Novartis Revolutionizes Clinical Trial Recruitment Through Digital Innovation and Social Media
- Novartis has launched a dedicated Twitter channel @NovartisCancrUS reaching nearly 10,000 followers to promote cancer clinical trials and facilitate patient recruitment in the United States.
- The company has developed an interactive global clinical trials database with GPS functionality, allowing patients worldwide to locate and connect with nearby trial opportunities.
- Novartis's innovative Signature trial program enables personalized cancer trials across the US, matching patients' genetic alterations to relevant drugs while allowing them to receive treatment closer to home.
Novartis Pharmaceuticals
Posted 5/1/2014